Daclatasvir Impurity 16 | CAS 2375084-73-2 - Request Quote
Daclatasvir Impurity 16
| SZ CAT No: | SZ-D036053 |
| CAS No | 2375084-73-2 |
| Mol.F. | C12H22N2O5 |
| Mol.Wt. |
274.3 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Daclatasvir Impurity 16 is chemically (Methoxycarbonyl)-L-valyl-L-valine. Daclatasvir Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Daclatasvir Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daclatasvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2375084-73-2
Purchase 2375084-73-2
Order 2375084-73-2
Enquire 2375084-73-2
price of 2375084-73-2
2375084-73-2 Supplier
2375084-73-2 Manufacturer
2375084-73-2 Exporter
buy high quality Daclatasvir Impurity 16
Purchase Daclatasvir Impurity 16
Daclatasvir Impurity 16 suppliers
Daclatasvir Impurity 16 manufacturers
Daclatasvir Impurity 16 price
Order Daclatasvir Impurity 16
Enquire Daclatasvir Impurity 16
Daclatasvir Impurity 16 cost
Daclatasvir Impurity 16 Supplier
Daclatasvir Impurity 16 Distributor
Daclatasvir Impurity 16 for Method Validation
Daclatasvir Reference Standard
Daclatasvir Impurity 16 for ANDA Filing
Daclatasvir Impurity 16 for Forced Degradation Studies
Daclatasvir Impurity 16 Identification Standards
Daclatasvir Impurity 16 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.